Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2025-12-31 @ 6:59 PM
Study NCT ID:
NCT00338234
Status:
COMPLETED
Last Update Posted:
2008-05-06
First Post:
2006-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Study Overview
Official Title:
Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients, Role of Hepcidin
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FAIRe
Brief Summary:
Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation.
Detailed Description:
Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation. The latter is known to interfere with iron metabolism, inducing iron storage instead of using it for hemoglobin synthesis. The discover of a new regulatory hormone of iron metabolism, hepcidin, may help us to better understand the link between inflammation and iron functional deficit. The aim of our study is to observe the variation of usual iron metabolism biological markers and of hepcidin, in order to define the better marker of iron loss in these clinical situations.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: